A new trading day began on Friday, with SpringWorks Therapeutics Inc (NASDAQ: SWTX) stock price down -5.19% from the previous day of trading, before settling in for the closing price of $35.26. SWTX’s price has ranged from $18.00 to $53.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.00% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 10.87%. With a float of $65.44 million, this company’s outstanding shares have now reached $73.49 million.
In an organization with 305 employees, it is important to assess its efficiency.
SpringWorks Therapeutics Inc (SWTX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of SpringWorks Therapeutics Inc is 11.68%, while institutional ownership is 99.93%. The most recent insider transaction that took place on Jun 03 ’24, was worth 1,955,113. In this transaction Chief Executive Officer of this company sold 49,000 shares at a rate of $39.90, taking the stock ownership to the 1,112,368 shares. Before that another transaction happened on Jun 03 ’24, when Company’s Chief Operating Officer sold 20,000 for $40.07, making the entire transaction worth $801,372. This insider now owns 249,600 shares in total.
SpringWorks Therapeutics Inc (SWTX) Latest Financial update
In its latest quarterly report, released on 3/31/2024, the company reported earnings of -1.25 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.87% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
Here are SpringWorks Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 93.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.99, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -3.47 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.91 million. That was inferior than the volume of 0.97 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.64%. Additionally, its Average True Range was 2.23.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 9.01%, which indicates a significant decrease from 17.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.31% in the past 14 days, which was higher than the 47.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.59, while its 200-day Moving Average is $38.84. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $34.56. Second resistance stands at $35.69. The third major resistance level sits at $37.20. If the price goes on to break the first support level at $31.92, it is likely to go to the next support level at $30.41. The third support level lies at $29.28 if the price breaches the second support level.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
With a market capitalization of 2.48 billion, the company has a total of 74,086K Shares Outstanding. Currently, annual sales are 5,450 K while annual income is -325,100 K. The company’s previous quarter sales were 21,010 K while its latest quarter income was -87,390 K.
